Oppenheimer & Co. Inc. cut its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 41.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 92,206 shares of the pharmacy operator’s stock after selling 64,506 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Walgreens Boots Alliance were worth $6,696,000 at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. Hudock Capital Group LLC boosted its stake in shares of Walgreens Boots Alliance by 0.5% during the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 6 shares in the last quarter. Northern Capital Management LLC boosted its stake in shares of Walgreens Boots Alliance by 0.4% during the second quarter. Northern Capital Management LLC now owns 6,635 shares of the pharmacy operator’s stock valued at $520,000 after purchasing an additional 25 shares in the last quarter. MAI Capital Management boosted its stake in shares of Walgreens Boots Alliance by 0.6% during the second quarter. MAI Capital Management now owns 5,272 shares of the pharmacy operator’s stock valued at $413,000 after purchasing an additional 34 shares in the last quarter. Truepoint Inc. boosted its stake in shares of Walgreens Boots Alliance by 0.5% during the second quarter. Truepoint Inc. now owns 8,614 shares of the pharmacy operator’s stock valued at $698,000 after purchasing an additional 39 shares in the last quarter. Finally, Girard Partners LTD. boosted its stake in shares of Walgreens Boots Alliance by 1.9% during the second quarter. Girard Partners LTD. now owns 3,053 shares of the pharmacy operator’s stock valued at $239,000 after purchasing an additional 56 shares in the last quarter. 61.57% of the stock is currently owned by institutional investors and hedge funds.
A number of analysts have recently commented on the company. Loop Capital set a $90.00 price target on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Tuesday. BidaskClub raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday, January 10th. Needham & Company LLC reissued a “buy” rating and set a $88.00 price target (up from $86.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, January 10th. ValuEngine lowered Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research note on Friday, February 2nd. Finally, Vetr lowered Walgreens Boots Alliance from a “strong-buy” rating to a “buy” rating in a research note on Friday, December 1st. Eleven equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $85.53.
Shares of Walgreens Boots Alliance Inc (WBA) opened at $68.29 on Wednesday. The firm has a market capitalization of $67,650.00, a P/E ratio of 18.86, a price-to-earnings-growth ratio of 1.16 and a beta of 1.18. The company has a quick ratio of 0.47, a current ratio of 0.96 and a debt-to-equity ratio of 0.48. Walgreens Boots Alliance Inc has a 1-year low of $63.82 and a 1-year high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.27 by $0.01. The business had revenue of $30.74 billion during the quarter, compared to the consensus estimate of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The firm’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same period in the previous year, the company posted $1.10 earnings per share. equities analysts anticipate that Walgreens Boots Alliance Inc will post 5.71 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, March 12th. Shareholders of record on Thursday, February 15th will be issued a $0.40 dividend. The ex-dividend date is Wednesday, February 14th. This represents a $1.60 dividend on an annualized basis and a yield of 2.34%. Walgreens Boots Alliance’s payout ratio is currently 44.20%.
Walgreens Boots Alliance announced that its Board of Directors has authorized a share buyback program on Wednesday, October 25th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the pharmacy operator to repurchase shares of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s board believes its stock is undervalued.
In other Walgreens Boots Alliance news, insider Stefano Pessina bought 98,858 shares of the stock in a transaction on Monday, January 15th. The stock was acquired at an average cost of $76.07 per share, for a total transaction of $7,520,128.06. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 14.80% of the company’s stock.
WARNING: This piece of content was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another website, it was stolen and reposted in violation of United States and international copyright & trademark laws. The correct version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/14/walgreens-boots-alliance-inc-wba-shares-sold-by-oppenheimer-co-inc.html.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.